REQUEST A DEMO
Total
USD $0.00
Search more companies

I.P.S. Endofertil S.A.S. (Colombia)

Main Activities: Ambulatory Health Care Services
Secondary Activities: Pharmacies and Drug Stores
Full name: I.P.S. Endofertil S.A.S. Profile Updated: October 02, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

I.P.S. Endofertil S.A.S. is an enterprise based in Colombia. Its main office is in Sincelejo. It operates in the Ambulatory Health Care Services sector. The enterprise was incorporated on June 22, 2017. The company’s latest financial report indicates a net sales revenue drop of 22.52% in 2025. There was a total negative growth of 5.8% in I.P.S. Endofertil S.A.S.’s total assets over the same period. The net profit margin of I.P.S. Endofertil S.A.S. decreased by 2.21% in 2025.

Headquarters
Cr 16 26 70 Brr Cruz De Colorado
Sincelejo; Sucre;

Contact Details: Purchase the I.P.S. Endofertil S.A.S. report to view the information.

Basic Information
Registered Capital:
Purchase the I.P.S. Endofertil S.A.S. report to view the information.
Financial Auditors:
Purchase the I.P.S. Endofertil S.A.S. report to view the information.
Incorporation Date:
June 22, 2017
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after I.P.S. Endofertil S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-22.52%
Total Operating Revenue
-22.52%
Operating Profit
-83.54%
EBITDA
-85.87%
Net Profit/Loss for the Period
-78.61%
Total Assets
-5.8%
Total Equity
3.78%
Operating Profit Margin
-19.87%
Net Profit Margin
-2.21%
Return on Equity (ROE)
-2.35%
Debt / Equity
-16.87%
Quick Ratio
0.46%
Cash Ratio
-0.13%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?